Patents Assigned to Bayer
  • Patent number: 6760668
    Abstract: In order to align DNA sequence data traces, an experimental data trace representing the positions of a first species of base within a target polynucleotide and a reference data trace representing the positions of a second species of base (which may be the same as or different from the first species) within a reference polynucleotide are obtained by separating appropriate sequencing fragments generated from the target and reference polynucleotides on an electrophoresis gel. For each reference data trace, a plurality of peaks corresponding to fragments having a size in the range of 40 to 1200 bases are selected. A base number is assigned to each of the selected peaks in the reference data trace, and a numerical “peak file” is created with information about the peak number and migration time (or distance).
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: July 6, 2004
    Assignee: Bayer HealthCare LLC
    Inventors: Alexandre Izmailov, Henryk Zaleski, Stephen Darasch
  • Patent number: 6759363
    Abstract: Activators with reduced volatility that are liquid at room temperature are obtained as the reaction product of (A) a secondary amine or primary alcohol having at least one tertiary amine group, (B) a polyisocyanate of the diphenylmethane series having a functionality of from 2.5 to 4.0 and an OH-functional reactive component capable of addition to isocyanate. These activators are useful for the production of polyurethane foams having improved emission behavior.
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: July 6, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Peter Haas, Dirk Wegener, Hartwig Grammes
  • Patent number: 6759558
    Abstract: A novel process allows a simple preparation of highly pure halogen-substituted dibenzyl alcohols by reduction of the corresponding halogen-substituted terephthalic acids and reaction with an alkylating agent, sulfuric acid, alkyl- or arylsulfonic acids. The highly pure halogen-substituted dibenzyl alcohols obtained are suitable in particular for preparing pharmaceutically or agrochemically active compounds.
    Type: Grant
    Filed: April 5, 2002
    Date of Patent: July 6, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventor: Lars Rodefeld
  • Publication number: 20040128704
    Abstract: The invention provides for the use of isolated polynucleotides encoding maize poly (ADP-ribose) polymerase (PARP) proteins to produce eukaryotic cells and organisms, particularly plant cells and plants, with modified programmed cell death. Eukaryotic cells and organisms particularly plant cells and plants, are provided wherein either in at least part of the cells, preferably selected cells, the programmed cell death (PCD) is provoked, or wherein, on the contrary, PCD of the cells or of at least part of the cells in an organism is inhibited, by modulation of the level or activity or PARP proteins in those cells.
    Type: Application
    Filed: November 12, 2003
    Publication date: July 1, 2004
    Applicant: BAYER BIOSCIENCE
    Inventors: Elena Babiychuk, Sergei Kushnir, Marc De Block
  • Publication number: 20040124079
    Abstract: The present invention discloses a process for the production of a gas diffusion electrode, in particular for the electrolysis of an aqueous solution of hydrogen chloride, in a first step a) a dispersion of a catalyst containing a noble metal and of a proton-conducting ionomer in an organic solvent being sprayed onto an electrically conductive support optionally provided with a coating material containing an acetylene black/polytetrafluoroethylene mixture and, in a second step b), the organic solvent being removed.
    Type: Application
    Filed: September 17, 2003
    Publication date: July 1, 2004
    Applicant: BAYER AG
    Inventors: Fritz Gestermann, Martin Sturmann, Gerd Speer, Michael Granz, Peter Kohl
  • Publication number: 20040127500
    Abstract: Matrix metalloprotease inhibiting compounds, pharmaceutical compositions thereof and a method of disease treatment using such compounds are presented.
    Type: Application
    Filed: December 12, 2003
    Publication date: July 1, 2004
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Michael C. VanZandt, David R. Brittelli, Brian R. Dixon
  • Patent number: 6756500
    Abstract: A process for preparing a cyclic compound comprising subjecting a starting material in the presence of a catalyst component to metathesis reaction in the presence of an ionic liquid, wherein the starting material is a &agr;,&ohgr;-diene bearing a &agr; substituent NRR1 in the &agr; position to a double bond, wherein R is hydrogen or an organic substituent, R1 is tert-butyl, P(R)2, P(R2)2, COR, SO2PhR, COOR or CONRR2, R2is alkyl or phenyl, or R and R1 together form and in which &agr;,&ohgr;-dienes optionally bear at least one further substituent R in any other position with the exception of the &agr; position, wherein R is selected from the group consisting of hydrogen, fused or unfused aryl, alkyl, CN, COOR2 or halogen, and wherein the starting material optionally contains a member selected from the group containing at least one further substituent that is inert in the metathesis reaction and a heteroatom selected from the group consisting of branched alkyl radicals, unbranched alkyl radical
    Type: Grant
    Filed: February 25, 2000
    Date of Patent: June 29, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Christoph Gürtler, Manfred Jautelat
  • Patent number: 6756464
    Abstract: The invention relates to a primer containing a solvent-containing two-component polyurethane binder comprising I) a curing component (A), comprising an addition product of at least one organic polyisocyanate (B) with an average NCO functionality of 2.5 to 5.0 and an isocyanate content of 8 to 27 wt. % and an alkoxysilane (C) of formula (I) with at least one isocyanate-reactive group, Q—Z—SiXaY3−a  (I), in which Q represents an isocyanate-reactive group, Z represents a linear or branched C1-C12 alkylene group, X represents a hydrolyzable group, Y represents identical or different C1-C4 alkyl groups and a is an integer from 1 to 3, and II) a lacquer resin (D) which can react with isocyanate groups as adhesion promoter.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: June 29, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Steffen Hofacker, Markus Mechtel, Wieland Hovestadt, Claus Kobusch
  • Patent number: 6756342
    Abstract: The invention relates to novel substituted thienocycloalk(en)ylamino-1,3,5-triazines of the general formula (I) in which Z, R1, R2, R3 are as defined in the description, and to processes for their preparation, to there use as herbicides and to the intermediates required for their preparation including their preparation processes in the case of the preferred compounds.
    Type: Grant
    Filed: March 4, 2002
    Date of Patent: June 29, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Kristian Kather, Stefan Lehr, Hans-Jochem Riebel, Katharina Voigt, Mark Wilhelm Drewes, Dieter Feucht, Rolf Pontzen, Ingo Wetcholowsky
  • Patent number: 6756409
    Abstract: The invention relates to novel phenoxyphenyl alkanesulphonates, processes for their preparation, their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment of states of pain and neurodegenerative disorders.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: June 29, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Markus Heil, Heinrich Meier, Paul Naab, Arnd Voerste, Jean-Marie-Viktor De Vry, Dirk Denzer, Frank Mauler, Klemens Lustig, Jan-Bernd Lenfers
  • Patent number: 6756439
    Abstract: A glass fiber reinforced thermoplastic molding composition suitable for the preparation of articles having good surface properties is disclosed. The composition contains a resinous blend and a filler component. The resinous blend contains (i) to 50 wt. % of a grafted acrylate rubber, (ii) 2 to 10 wt. % of a first copolymer containing structural units derived from styrene (meth)acrylonitrile and maleic anhydride, (iii) 20 to 80 wt. % polyamide, and (iv) 0 to 40 wt. % of a second copolymer containing structural units derived from styrene and (meth)acrylonitrile, the percents being relative to the total amount of (i), (ii), (iii) and (iv). The filler component of the inventive composition contains 5 to 50 percent of milled glass fibers, the percent being relative to the weight of the molding composition. Optionally, the inventive composition also contains a positive amount of a wollastonite. Molded articles that are prepared of the composition feature good mechanical properties and excellent surface quality.
    Type: Grant
    Filed: March 21, 2002
    Date of Patent: June 29, 2004
    Assignee: Bayer Polymers LLC
    Inventor: Moh-Ching Oliver Chang
  • Patent number: 6756473
    Abstract: Process for the preparation of neutral poly(ethylene-3,4-dioxythiophenes) of the general formula (I) in which R1 and R2, independently of one another, each represent H or C1 to C9-alkyl, it also being possible for R2 to be CH2—O—R3 with R3=H or C1 to C9-alkyl, cycloalkyl or aralkyl, when R1 represents H, and n represents 2 to 200, suitable thiophene monomers being reacted in an organic solvent with an oxidizing agent and the oxidizing agent being used in 50 to 99.9% of the stoichiometrically required amount. The neutral poly(ethylene-3,4-dioxythiophenes) thus obtainable are distinguished in particular by their solubility in organic solvents.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: June 29, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Knud Reuter, Stephan Kirchmeyer
  • Patent number: 6756433
    Abstract: The present invention relates to polycarbonate moulding compositions provided with phosphonate amines and phosphorus compounds, which moulding compositions exhibit excellent flame protection and very good mechanical properties, such as joint line strength or modulus of elasticity, and a good crude shade.
    Type: Grant
    Filed: February 27, 2002
    Date of Patent: June 29, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Michael Zobel, Thomas Eckel, Torsten Derr, Dieter Wittmann
  • Patent number: 6756512
    Abstract: The invention relates to a novel process for preparing 2-alkyl-3-chlorophenols.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: June 29, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Walter Hübsch, Reinhard Lantzsch, Thorsten Müh, Holger Weintritt
  • Patent number: 6756234
    Abstract: It has been found that casein and salts of casein are useful as replacements for, or in addition to, BSA as materials for coating solid phases, particularly magnetic particles, used for immunoassays and other binding assays for separation of the desired analyte. By using casein, immunoassays having improved stability and few discordant samples have been developed. Casein used at a concentration of 0.05-4.0 grams per gram of paramagnetic particle (optimally approximately 0.78-1.2 grams of casein per gram of magnetic particle) has been found to confer this benefit. In addition, a process for coating solid phases has been invented, said process comprising the mixing of casein with magnetic particles at 30-60° C. for 5-180 hours, said process resulting in casein-coated paramagnetic particles which either (1) already have combined therewith active ingredients needed in the binding assay or (2) are capable of reacting with active ingredients needed in the binding assay.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: June 29, 2004
    Assignee: Bayer Corporation
    Inventors: Wei-Chao Ni, Daniel W. Eustace, Steve Chin-Shen Chang
  • Publication number: 20040121375
    Abstract: The present invention also relates to biomarkers and the use of biomarkers for the prediction and prognosis of cancer as well as the use of biomarkers to monitor the efficacy of cancer treatment. Specifically, this invention relates to the use of adrenomedullin as a biomarker for Raf kinase inhibitors.
    Type: Application
    Filed: September 30, 2003
    Publication date: June 24, 2004
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Deepa Eveleigh, Ian Taylor
  • Publication number: 20040122004
    Abstract: The present invention relates to substituted phenylcyclohexanecarboxamides of the Formula (I) 1
    Type: Application
    Filed: November 17, 2003
    Publication date: June 24, 2004
    Applicant: Bayer Aktiengesellschaft
    Inventors: Erwin Bischoff, Thomas Krahn, Stephan-Nicholas Muller, Holger Paulsen, Joachim Schuhmacher, Henning Steinhagen, Wolfgang Thielemann
  • Patent number: 6753444
    Abstract: The invention relates to a process for preparing 2,3,5,6-tetrahaloxylylidene compounds of formula (I) where each Hal is independently fluorine or chlorine, and X is fluorine, chlorine, bromine, —O—R, or —O—C(═O)R, where R is hydrogen, a straight-chain or branched C1-C12-alkyl- or a C6-C14-aryl radical, by reacting 2,3,5,6-tetrahaloxylylidenediamines of formula (II) with an alkyl nitrite and/or nitrous acid in HX as a solvent.
    Type: Grant
    Filed: July 24, 2002
    Date of Patent: June 22, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Reinhard Langer, Lars Rodefeld
  • Patent number: 6753405
    Abstract: A process for the preparation of transparent copolycarbonate is disclosed. The copolycarbonate the molecular structure of which contains more than 35 mole % of units derived from dihydroxydiphenylene is prepared by the melt transesterification process wherein the final temperature of the reaction is reached in less than 40 minutes after reaching the starting temperature.
    Type: Grant
    Filed: July 12, 2002
    Date of Patent: June 22, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Silke Kratschmer, Lothar Bunzel, Hans Deml
  • Patent number: 6753298
    Abstract: Compositions for controlling diseases caused by protozoans of the genus Neospora, which are characterized in that they comprise one or more active compounds which inhibit the microtubulin system of plants.
    Type: Grant
    Filed: December 2, 2002
    Date of Patent: June 22, 2004
    Assignee: Bayer AG
    Inventors: Gisela Greif, Folker Lieb, Carl Fedtke